Lipid composition of the cerebellum and spinal cord in postnatal cycasin-treated Swiss albino mice: preliminary observations.
D000818:Animals; D000831:Animals, Newborn; D001391:Azo Compounds / Q000494:pharmacology*; D001921:Brain / Q000033:anatomy & histology / Q000254:growth & development; D002273:Carcinogens / Q000494:pharmacology*; D002531:Cerebellum / Q000033:anatomy & histology / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology; D006027:Glycosides / Q000494:pharmacology*; D050356:Lipid Metabolism; D000432:Methanol / Q000494:pharmacology; D051379:Mice; D009929:Organ Size; D010713:Phosphatidylcholines / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D013109:Sphingomyelins / Q000378:metabolism; D013116:Spinal Cord / Q000187:drug effects* / Q000378:metabolism
D001391:Azo Compounds; D002273:Carcinogens; D006027:Glycosides; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010716:Phosphatidylinositols; D010743:Phospholipids; D013109:Sphingomyelins; D002784:Cholesterol; D005947:Glucose; D000432:Methanol